- Home
- UHS vs SNN Comparison
UHS vs SNN Comparison
Compare UHS & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UHS
- SNN
- Stock Information
- Founded
- UHS 1978
- SNN 1856
- Country
- UHS United States
- SNN United Kingdom
- Employees
- UHS N/A
- SNN N/A
- Industry
- UHS Hospital/Nursing Management
- SNN Industrial Specialties
- Sector
- UHS Health Care
- SNN Health Care
- Exchange
- UHS Nasdaq
- SNN Nasdaq
- Market Cap
- UHS 10.0B
- SNN 13.2B
- IPO Year
- UHS N/A
- SNN 1999
- Fundamental
- Price
- UHS $165.48
- SNN $30.93
- Analyst Decision
- UHS Buy
- SNN Hold
- Analyst Count
- UHS 15
- SNN 3
- Target Price
- UHS $222.07
- SNN $27.50
- AVG Volume (30 Days)
- UHS 965.4K
- SNN 1.0M
- Earning Date
- UHS 07-28-2025
- SNN 08-08-2025
- Dividend Yield
- UHS 0.48%
- SNN 2.33%
- EPS Growth
- UHS 39.27
- SNN 56.15
- EPS
- UHS 18.95
- SNN 0.47
- Revenue
- UHS $16,460,285,000.00
- SNN $5,810,000,000.00
- Revenue This Year
- UHS $9.37
- SNN $6.87
- Revenue Next Year
- UHS $5.27
- SNN $5.19
- P/E Ratio
- UHS $8.73
- SNN $33.43
- Revenue Growth
- UHS 9.61
- SNN 4.70
- 52 Week Low
- UHS $152.33
- SNN $23.69
- 52 Week High
- UHS $243.25
- SNN $31.84
- Technical
- Relative Strength Index (RSI)
- UHS 43.14
- SNN 54.35
- Support Level
- UHS $152.33
- SNN $31.09
- Resistance Level
- UHS $174.38
- SNN $31.60
- Average True Range (ATR)
- UHS 5.85
- SNN 0.39
- MACD
- UHS -1.04
- SNN 0.06
- Stochastic Oscillator
- UHS 40.25
- SNN 64.59
About UHS Universal Health Services Inc.
Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two segments: Acute Care Hospital Services and Behavioral Health Services. The company generates the majority of its revenue from the Acute Care Hospital Services segment. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.